Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High-Impact Trials with Genetic and -Omics Information Focus on Cancer Mutations, are Industry-Funded and Less Transparent

SSRN Electronic Journal(2024)10.2139/ssrn.5014729Source: DataRank Database

High-Impact Trials with Genetic and -Omics Information Focus on Cancer Mutations, are Industry-Funded and Less Transparent is a research paper published in SSRN Electronic Journal (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (17)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Sara Farina ORCID,Roberta Pastorino ORCID,Stefania Boccia ORCID,John P. A. Ioannidis ORCID,Leonardo Maria Siena ORCID

Live enrichment

PubMed:20725694 OpenAlex:https://openalex.org/W4404584200

European Commission

Grant: 823995

European network staff eXchange for integrAting precision health in the health Care sysTems

greenLicense: Elsevier TDM

repositoryhttp://doi.org/10.2139/ssrn.5014729

https://doi.org/10.2139/ssrn.5014729

https://doi.org/10.1016/j.jclinepi.2025.111676

https://pubmed.ncbi.nlm.nih.gov/39826627

Fields of Study

Cancer Genomics and DiagnosticsGenetics, Bioinformatics, and Biomedical ResearchScience, Research, and Medicine

Keywords

Focus (optics)OmicsCancerComputational biologyBiologyGeneticsBioinformaticsClinical Trials as TopicDrug IndustryNeoplasmsMutationHumansGenomicscancer; clinical trials; genetics; genomics; industry; transparency

Sustainable Development Goals

SDG 0: Industry, innovation and infrastructure